160 related articles for article (PubMed ID: 15134520)
1. Semicarbazide-sensitive amine oxidase: current status and perspectives.
Mátyus P; Dajka-Halász B; Földi A; Haider N; Barlocco D; Magyar K
Curr Med Chem; 2004 May; 11(10):1285-98. PubMed ID: 15134520
[TBL] [Abstract][Full Text] [Related]
2. Potential therapeutic value of drugs inhibiting semicarbazide-sensitive amine oxidase: vascular cytoprotection in diabetes mellitus.
Ekblom J
Pharmacol Res; 1998 Feb; 37(2):87-92. PubMed ID: 9572061
[TBL] [Abstract][Full Text] [Related]
3. Diabetes and semicarbazide-sensitive amine oxidase (SSAO) activity: a review.
Obata T
Life Sci; 2006 Jun; 79(5):417-22. PubMed ID: 16487546
[TBL] [Abstract][Full Text] [Related]
4. Physiological and pathological implications of semicarbazide-sensitive amine oxidase.
Yu PH; Wright S; Fan EH; Lun ZR; Gubisne-Harberle D
Biochim Biophys Acta; 2003 Apr; 1647(1-2):193-9. PubMed ID: 12686132
[TBL] [Abstract][Full Text] [Related]
5. Selective inhibitors of membrane-bound semicarbazide-sensitive amine oxidase (SSAO) activity in mammalian tissues.
Kinemuchi H; Sugimoto H; Obata T; Satoh N; Ueda S
Neurotoxicology; 2004 Jan; 25(1-2):325-35. PubMed ID: 14697907
[TBL] [Abstract][Full Text] [Related]
6. 2-Bromoethylamine as a potent selective suicide inhibitor for semicarbazide-sensitive amine oxidase.
Yu PH; Davis BA; Deng Y
Biochem Pharmacol; 2001 Mar; 61(6):741-8. PubMed ID: 11266660
[TBL] [Abstract][Full Text] [Related]
7. Involvement of SSAO-mediated deamination in adipose glucose transport and weight gain in obese diabetic KKAy mice.
Yu PH; Wang M; Fan H; Deng Y; Gubisne-Haberle D
Am J Physiol Endocrinol Metab; 2004 Apr; 286(4):E634-41. PubMed ID: 14656718
[TBL] [Abstract][Full Text] [Related]
8. Anti-inflammatory effects of inhibiting the amine oxidase activity of semicarbazide-sensitive amine oxidase.
Salter-Cid LM; Wang E; O'Rourke AM; Miller A; Gao H; Huang L; Garcia A; Linnik MD
J Pharmacol Exp Ther; 2005 Nov; 315(2):553-62. PubMed ID: 16081681
[TBL] [Abstract][Full Text] [Related]
9. Inhibitor sensitivity of human serum and vascular semicarbazide-sensitive amine oxidases.
Mészáros Z; Csányi A; Vallus G; Szombathy T; Karádi I; Magyar K
Neurobiology (Bp); 2000; 8(2):215-23. PubMed ID: 11061216
[TBL] [Abstract][Full Text] [Related]
10. Deamination of aliphatic amines by type B monoamine oxidase and semicarbazide-sensitive amine oxidase; pharmacological implications.
Yu PH; Davis BA; Boulton AA; Zuo DM
J Neural Transm Suppl; 1994; 41():397-406. PubMed ID: 7931256
[TBL] [Abstract][Full Text] [Related]
11. Semicarbazide-sensitive amine oxidase (SSAO): from cell to circulation.
Boomsma F; Hut H; Bagghoe U; van der Houwen A; van den Meiracker A
Med Sci Monit; 2005 Apr; 11(4):RA122-6. PubMed ID: 15795708
[TBL] [Abstract][Full Text] [Related]
12. Mammalian plasma and tissue-bound semicarbazide-sensitive amine oxidases: biochemical, pharmacological and toxicological aspects.
Lyles GA
Int J Biochem Cell Biol; 1996 Mar; 28(3):259-74. PubMed ID: 8920635
[TBL] [Abstract][Full Text] [Related]
13. Production of a truncated soluble human semicarbazide-sensitive amine oxidase mediated by a GST-fusion protein secreted from HEK293 cells.
Ohman J; Jakobsson E; Källström U; Elmblad A; Ansari A; Kalderén C; Robertson E; Danielsson E; Gustavsson AL; Varadi A; Ekblom J; Holmgren E; Doverskog M; Abrahmsén L; Nilsson J
Protein Expr Purif; 2006 Apr; 46(2):321-31. PubMed ID: 16325418
[TBL] [Abstract][Full Text] [Related]
14. Deamination of methylamine and angiopathy; toxicity of formaldehyde, oxidative stress and relevance to protein glycoxidation in diabetes.
Yu PH
J Neural Transm Suppl; 1998; 52():201-16. PubMed ID: 9564620
[TBL] [Abstract][Full Text] [Related]
15. Plasma semicarbazide-sensitive amine oxidase is elevated in patients with congestive heart failure.
Boomsma F; van Veldhuisen DJ; de Kam PJ; Man in't Veld AJ; Mosterd A; Lie KI; Schalekamp MA
Cardiovasc Res; 1997 Feb; 33(2):387-91. PubMed ID: 9074703
[TBL] [Abstract][Full Text] [Related]
16. The Impact of Semicarbazide Sensitive Amine Oxidase Activity on Rat Aortic Vascular Smooth Muscle Cells.
Manasieva V; Thakur S; Lione LA; Baydoun AR; Skamarauskas J
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902376
[TBL] [Abstract][Full Text] [Related]
17. [Determination of serum semicarbazide-sensitive amine oxidase activity in diabetic retinopathy in type-2 diabetes].
Dura E; Mészáros Z; Salacz G; Magyar K; Romics L; Karádi I
Orv Hetil; 2002 Nov; 143(47):2637-44. PubMed ID: 12532650
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of semicarbazide-sensitive amine oxidase reduces atherosclerosis in apolipoprotein E-deficient mice.
Wang SH; Yu TY; Tsai FC; Weston CJ; Lin MS; Hung CS; Kao HL; Li YI; Solé M; Unzeta M; Chen YL; Chuang LM; Li HY
Transl Res; 2018 Jul; 197():12-31. PubMed ID: 29653075
[TBL] [Abstract][Full Text] [Related]
19. Oxidative deamination of methylamine by semicarbazide-sensitive amine oxidase leads to cytotoxic damage in endothelial cells. Possible consequences for diabetes.
Yu PH; Zuo DM
Diabetes; 1993 Apr; 42(4):594-603. PubMed ID: 8454111
[TBL] [Abstract][Full Text] [Related]
20. Anti-inflammatory effects of LJP 1586 [Z-3-fluoro-2-(4-methoxybenzyl)allylamine hydrochloride], an amine-based inhibitor of semicarbazide-sensitive amine oxidase activity.
O'Rourke AM; Wang EY; Miller A; Podar EM; Scheyhing K; Huang L; Kessler C; Gao H; Ton-Nu HT; Macdonald MT; Jones DS; Linnik MD
J Pharmacol Exp Ther; 2008 Feb; 324(2):867-75. PubMed ID: 17993604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
